FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?
In Brief: Ginder To direct Massey Cancer Center; UAB Receives $1 Million for Genetics Chair
National Action Plan: Steering committee Votes No Confidence In HHS Official.
Professional Societies: Tobacco Industry Should Pay For Research, AACR Says
Federal Funding: IOM Report Praises DOD Breast Cancer Research Program
NCI RFA Available: Minority-Based CCOPS
Trending Stories
- Karen Knudsen to leave ACS
- A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease
- Factors outside CAR T-cell therapy are associated with increased risk of secondary cancers after the treatment, meta-analysis shows
Subgroup analysis suggests risk of secondary cancers after CAR T-cell therapy is similar to risk after other therapies - Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72
- Mace Rothenberg’s museum will tell the stories behind breakthroughs in medicine
- Melanoma investigators invite FDA to publicly discuss approval endpoints and crossover design
The agency accepts the invitation